drugset / Trial / NCT02930005
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the feasibility of administering meclofenamic acid or pentosan polysulfate sodium as an adjunctive treatment to patients diagnosed with a psychotic disorder. Half of participants will receive meclofenamic acid, while the other half will receive polysulfate sodium.
Timeline
- Start
- 2015-08-07
- Primary completion
- 2016-10-06
- Completion
- 2016-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meclofenamic acid | Unknown | 150 mg | — |
| Subject | Pentosan Polysulfate Sodium | Small molecule | 300 mg | — |